<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> and immune system activation seem to play an important role in the development and progression of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> is common in various forms of <z:hpo ids='HP_0000726'>dementia</z:hpo>, and a significant relationship was found between concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and immune activation marker neopterin </plain></SENT>
<SENT sid="2" pm="."><plain>B vitamin supplementation is able to slow-down <z:chebi fb="0" ids="17230">homocysteine</z:chebi> formation in patients </plain></SENT>
<SENT sid="3" pm="."><plain>In an open-label study, effects of B vitamin supplementation (Beneuran compositum ) on concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and neopterin were investigated in 58 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n=30), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (n=12) and mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (n=16) </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> groups of patients, a significant percentage of patients presented with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations &gt;15 micromol/L and with elevated concentrations of immune activation marker neopterin </plain></SENT>
<SENT sid="5" pm="."><plain>Decline of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations was observed after one month of B vitamin supplementation (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.01; paired Kruskal-Wallisn-test) </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, neopterin concentrations remained unchanged (<z:hpo ids='HP_0000001'>all</z:hpo> p&gt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>B vitamin supplementation in patients with various forms of <z:hpo ids='HP_0000726'>dementia</z:hpo> did not influence neopterin concentrations, which indicates that the degree of immune activation and <z:mp ids='MP_0001845'>inflammation</z:mp> remained unchanged </plain></SENT>
<SENT sid="8" pm="."><plain>The question remains, if lowering of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> by <z:chebi fb="3" ids="37445">folate</z:chebi> supplementation alone could have any beneficial effect to modulate the course of <z:hpo ids='HP_0000726'>dementia</z:hpo> development and if longer period of supplementation would also ameliorate immune system activation status </plain></SENT>
</text></document>